<DOC>
	<DOCNO>NCT02499939</DOCNO>
	<brief_summary>The primary purpose trial determine preliminary efficacy therapeutic ultrasound treatment pain sensory disturbance relate chemotherapy induced peripheral neuropathy .</brief_summary>
	<brief_title>Ultrasound Therapy Therapeutic Exercise Chemotherapy Induced Peripheral Neuropathy ( CIPN )</brief_title>
	<detailed_description>Thirty cancer patient colon colorectal cancer undergo chemotherapy treatment include agent oxaliplatin take part study . Patients randomly assign either standard care alone ( education therapeutic exercise ) standard care plus 10 treatment therapeutic ultrasound toe finger . Participants group follow home exercise program 6 week period . Therapeutic ultrasound administer daily ( e.g. , Monday Friday ) first two week period study .</detailed_description>
	<mesh_term>Neoplasms</mesh_term>
	<mesh_term>Peripheral Nervous System Diseases</mesh_term>
	<mesh_term>Colorectal Neoplasms</mesh_term>
	<mesh_term>Colonic Neoplasms</mesh_term>
	<criteria>1. adults18 old , 2. receive receive chemotherapy treatment colon colorectal cancer , 3. chemotherapy regimen include agent oxaliplatin , 4 . Grade 1 , 2 3 National Cancer Institute Common Terminology Criteria Adverse Events sensory motor neuropathy . 1. neuropathy preexist patient 's cancer diagnosis ; 2. contraindication therapeutic ultrasound : active cancer region hand foot , presence deep vein thrombosis , lack sensation hand foot , metal plastic implant hand foot ; 3. peripheral vascular disease serious exist nonmalignant disease may affect ability complete test treatment session .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
</DOC>